Stock Ownership/BLRX

BIOLINE RX LIMITED (BLRX): Ownership & Insider Activity

Hedge funds and institutional managers reporting a position in BLRX · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.

Reported Holders
2
13F filers
Aggregate Value
$94K
Across holders
Last Price
$2.01
2026-10-16
Sector
Health Care
GICS
Quarterly fund activity2 increased0 reduced1 exited
Full exits: Rockefeller Capital Management L.P.
Institutional Holders of BLRX
↗
2 holders
Manager⇅Type⇅Shares⇅Market Value▼% of Total⇅% of Portfolio⇅Action⇅QoQ Change⇅Quarter⇅
RENAISSANCE TECHNOLOGIES LLC
CIK 0001037389
Hedge Fund15K$48K51.2%0.0%Added—Q2 2026
CITADEL ADVISORS LLC
CIK 0001423053
Hedge Fund15K$46K48.8%0.0%Added—Q2 2026
RENAISSANCE TECHNOLOGIES LLCAdded
Hedge Fund
$48K· 51.2% of total· 0.0% port· 15K sh· — QoQ· Q2 2026
CITADEL ADVISORS LLCAdded
Hedge Fund
$46K· 48.8% of total· 0.0% port· 15K sh· — QoQ· Q2 2026
Loading recent insider activity…
← Stock ownership